KLP Kapitalforvaltning
ABUS icon

KLP Kapitalforvaltning’s Arbutus Biopharma ABUS Stock Holding History

KLP Kapitalforvaltning’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$148K Hold
30,900
– – ﹤0.01% 1975
2026
Q2 		$148K Hold
30,900
– – ﹤0.01% 2004
2026
Q1 		$139K Hold
30,900
– – ﹤0.01% 1955
2025
Q4 		$149K Buy
30,900
+5,300
+21% +$23.8K ﹤0.01% 1941
2025
Q3 		$116K Hold
25,600
– – ﹤0.01% 2024
2025
Q2 		$79.1K Hold
25,600
– – ﹤0.01% 2099
2025
Q1 		$89.3K Hold
25,600
– – ﹤0.01% 2063
2024
Q4 		$83.7K Buy
+25,600
New +$94.2K ﹤0.01% 2142

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return

KLP Kapitalforvaltning's ABUS Position: Q3 2026 in Review

KLP Kapitalforvaltning held its Arbutus Biopharma (ABUS) position steady in Q3 2026 at 30,900 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

KLP Kapitalforvaltning first reported a position in ABUS in Q4 2024 and has held it in 8 quarters since. The position peaked at $149K in Q4 2025. 150 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • KLP Kapitalforvaltning held 30,900 shares of Arbutus Biopharma worth $148K as of Q3 2026.
  • KLP Kapitalforvaltning left its Arbutus Biopharma share count unchanged in Q3 2026.
  • Arbutus Biopharma made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #1975 holding.
  • KLP Kapitalforvaltning first reported a position in Arbutus Biopharma in Q4 2024 and has held it in 8 quarters since.
  • KLP Kapitalforvaltning's Arbutus Biopharma position peaked at $149K in Q4 2025.
  • 150 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.